Patient-Focused Drug Development on Chronic Pain; Public Meeting; Request for Comments

We encourage patients with chronic pain to submit written comments for FDA’s Chronic Pain Patient-Focused Drug Development meeting.   https://www.regulations.gov/document?D=FDA-2018-N-1621-0001